7-30752256-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006774.5(INMT):c.106G>A(p.Glu36Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,046 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006774.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INMT | NM_006774.5 | c.106G>A | p.Glu36Lys | missense_variant | 1/3 | ENST00000013222.5 | NP_006765.4 | |
INMT | NM_001199219.2 | c.106G>A | p.Glu36Lys | missense_variant | 1/3 | NP_001186148.1 | ||
INMT-MINDY4 | NR_037598.1 | n.122G>A | non_coding_transcript_exon_variant | 1/20 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INMT | ENST00000013222.5 | c.106G>A | p.Glu36Lys | missense_variant | 1/3 | 1 | NM_006774.5 | ENSP00000013222.5 | ||
INMT-MINDY4 | ENST00000458257.5 | n.106G>A | non_coding_transcript_exon_variant | 1/20 | 2 | ENSP00000456039.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251444Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135898
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461860Hom.: 1 Cov.: 33 AF XY: 0.0000550 AC XY: 40AN XY: 727234
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2024 | The c.106G>A (p.E36K) alteration is located in exon 1 (coding exon 1) of the INMT gene. This alteration results from a G to A substitution at nucleotide position 106, causing the glutamic acid (E) at amino acid position 36 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at